{"altmetric_id":14165161,"counts":{"readers":{"mendeley":15,"citeulike":0,"connotea":0},"total":{"posts_count":10},"twitter":{"unique_users_count":10,"unique_users":["FrontImmunol","BLouMAtRiX","denhud","InmunoMedUMU","DesanctisJuan","CICS_DR_MARQUEZ","NextGEN_Ltd","LorenaMontijo","Francis_Rdgz","DrKynast"],"posts_count":10}},"selected_quotes":["Immunology MENA crimes: Cologne New Year Eve 2015 riots BerlinParis London attacks: political analogon 4 graft versus host disease ?"],"citation":{"abstract":"Graft-versus-host response after allogeneic hematopoietic stem cell transplantation (allo-HCT) represents one of the most intense inflammatory responses observed in humans. Host conditioning facilitates engraftment of donor cells, but the tissue injury caused from it primes the critical first steps in the development of acute graft-versus-host disease (GVHD). Tissue injuries release pro-inflammatory cytokines (such as TNF-\u03b1, IL-1\u03b2, and IL-6) through widespread stimulation of pattern recognition receptors (PRRs) by the release of danger stimuli, such as damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs). DAMPs and PAMPs function as potent stimulators for host and donor-derived antigen presenting cells (APCs) that in turn activate and amplify the responses of alloreactive donor T cells. Emerging data also point towards a role for suppression of DAMP induced inflammation by the APCs and donor T cells in mitigating GVHD severity. In this review, we summarize the current understanding on the role of danger stimuli, such as the DAMPs and PAMPs, in GVHD.","altmetric_jid":"4f6fa90c3cf058f61000cb02","authors":["Toubai, Tomomi","Mathewson, Nathan D.","Magenau, John","Reddy, Pavan"],"doi":"10.3389\/fimmu.2016.00539","first_seen_on":"2016-11-29T19:37:16+00:00","funders":["nci","niehs","nhlbi"],"issns":["1664-3224"],"journal":"Frontiers in immunology","last_mentioned_on":1497565528,"links":["http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00539\/full?utm_source=dlvr.it&utm_medium=twitter"],"pdf_url":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00539\/pdf","pmcid":"PMC5126092","pmid":"27965667","pubdate":"2016-11-29T00:00:00+00:00","publisher":"Frontiers","title":"Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives","type":"article","volume":"7","mendeley_url":"http:\/\/www.mendeley.com\/research\/danger-signals-graftversushost-disease-current-understanding-future-perspectives-1"},"altmetric_score":{"score":4.7,"score_history":{"1y":4.7,"6m":0.25,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.7},"context_for_score":{"all":{"total_number_of_other_articles":8420753,"mean":7.0857638519611,"rank":1747856,"this_scored_higher_than_pct":79,"this_scored_higher_than":6663760,"rank_type":"exact","sample_size":8420753,"percentile":79},"similar_age_3m":{"total_number_of_other_articles":283372,"mean":11.892804549512,"rank":77597,"this_scored_higher_than_pct":72,"this_scored_higher_than":205156,"rank_type":"exact","sample_size":283372,"percentile":72},"this_journal":{"total_number_of_other_articles":3728,"mean":3.0963885162329,"rank":489,"this_scored_higher_than_pct":86,"this_scored_higher_than":3226,"rank_type":"exact","sample_size":3728,"percentile":86},"similar_age_this_journal_3m":{"total_number_of_other_articles":612,"mean":5.2178821603928,"rank":126,"this_scored_higher_than_pct":78,"this_scored_higher_than":483,"rank_type":"exact","sample_size":612,"percentile":78}}},"demographics":{"poster_types":{"member_of_the_public":8,"practitioner":2},"users":{"twitter":{"cohorts":{"Members of the public":8,"Practitioners (doctors, other healthcare professionals)":2}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":2,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":4,"Student  > Postgraduate":1,"Student  > Master":2,"Professor":2},"by_discipline":{"Medicine and Dentistry":8,"Chemistry":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":4,"Nursing and Health Professions":1}}},"geo":{"twitter":{"CH":1,"US":1,"FR":1,"VE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/FrontImmunol\/statuses\/803684211945152512","license":"gnip","citation_ids":[14165161],"posted_on":"2016-11-29T19:37:02+00:00","author":{"name":"Frontiers Immunology","url":"http:\/\/frontiersin.org\/Immunology","image":"https:\/\/pbs.twimg.com\/profile_images\/533290695813918721\/D6Z7R9Qu_normal.jpeg","description":"The official Twitter Feed for all the latest open-access peer-reviewed articles appearing in Frontiers in Immunology.  Impact Factor: 6.429.","id_on_source":"FrontImmunol","tweeter_id":"397381576","geo":{"lt":46.516,"ln":6.63282,"country":"CH"},"followers":3852},"tweet_id":"803684211945152512"},{"url":"http:\/\/twitter.com\/BLouMAtRiX\/statuses\/803685033458307072","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-11-29T19:40:18+00:00","author":{"name":"BLMatriX","url":"http:\/\/louis-solar-banks.tumblr.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/784931405885124608\/gpgFVfxo_normal.jpg","description":"B.Louis.Marcus 9122472205, conspiracy comic, theoretician, LouisIAna513 Capital LBankOfficer. Interpreter. Rescue Me SOS","id_on_source":"BLouMAtRiX","tweeter_id":"2460449173","geo":{"lt":32.08354,"ln":-81.09983,"country":"US"},"followers":492},"tweet_id":"803685033458307072"},{"url":"http:\/\/twitter.com\/denhud\/statuses\/803686911030206464","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-11-29T19:47:46+00:00","author":{"name":"Denis Hudrisier","url":"http:\/\/amprugby-denhud.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1124152119\/Capture_d__cran_2010-09-15___08.50.15_normal.png","description":"I love immunology (http:\/\/immunoblogonline.blogspot.fr\/) , research on tuberculosis, south africa, rugby, ubuntu, trogocytosis and education.","id_on_source":"denhud","tweeter_id":"190725328","geo":{"lt":43.60426,"ln":1.44367,"country":"FR"},"followers":339},"tweet_id":"803686911030206464"},{"url":"http:\/\/twitter.com\/InmunoMedUMU\/statuses\/803729597716111360","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-11-29T22:37:23+00:00","author":{"name":"PedroAparicio","image":"https:\/\/pbs.twimg.com\/profile_images\/786132948357709824\/Byu_MNYo_normal.jpg","description":"Profesor inmunolog\u00eda Universidad de Murcia.Facebook pedro.aparicio.100","id_on_source":"InmunoMedUMU","tweeter_id":"786118672343457793","geo":{"lt":null,"ln":null},"followers":139},"tweet_id":"803729597716111360"},{"url":"http:\/\/twitter.com\/DesanctisJuan\/statuses\/803755675776143360","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-11-30T00:21:00+00:00","author":{"name":"Juan B. De Sanctis","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000711357584\/5281967f704a91da496468cab3872fc2_normal.jpeg","description":"Profesor Titular y Director. Instituto de Inmunolog\u00eda. UCV","id_on_source":"DesanctisJuan","tweeter_id":"2176625564","geo":{"lt":8,"ln":-66,"country":"VE"},"followers":199},"tweet_id":"803755675776143360"},{"url":"http:\/\/twitter.com\/CICS_DR_MARQUEZ\/statuses\/803787147962679297","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-11-30T02:26:04+00:00","author":{"name":"CICS Sonora & USA","url":"http:\/\/www.cicsonusa.org","image":"https:\/\/pbs.twimg.com\/profile_images\/907387845605711872\/7EFMUd95_normal.jpg","description":"We are Physician Scientists performing clinically relevant oncology research for childhood & adult cancer. We belong to the binational IMMUNOONCOLOGY alliance.","id_on_source":"CICS_DR_MARQUEZ","tweeter_id":"744606863224774656","geo":{"lt":null,"ln":null},"followers":2506},"tweet_id":"803787147962679297"},{"url":"http:\/\/twitter.com\/NextGEN_Ltd\/statuses\/803840939877863427","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-11-30T05:59:49+00:00","author":{"name":"\u0412\u043b\u0430\u0434","image":"https:\/\/pbs.twimg.com\/profile_images\/2342353963\/irjhyyc7ed67fugjx2fk_normal.jpeg","id_on_source":"NextGEN_Ltd","tweeter_id":"443359139","geo":{"lt":null,"ln":null},"followers":89},"tweet_id":"803840939877863427"},{"url":"http:\/\/twitter.com\/LorenaMontijo\/statuses\/804358193052667904","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-12-01T16:15:12+00:00","author":{"name":"Lorena Montijo","image":"https:\/\/pbs.twimg.com\/profile_images\/865015154789961728\/KVydcNnB_normal.jpg","description":"CancerVac Fellow, Sonora Cancer Research Center","id_on_source":"LorenaMontijo","tweeter_id":"621575514","geo":{"lt":null,"ln":null},"followers":565},"tweet_id":"804358193052667904"},{"url":"http:\/\/twitter.com\/Francis_Rdgz\/statuses\/804373107448238080","license":"gnip","rt":["FrontImmunol"],"citation_ids":[14165161],"posted_on":"2016-12-01T17:14:28+00:00","author":{"name":"@CICS_Mtra_Francis","image":"https:\/\/pbs.twimg.com\/profile_images\/869247591409569792\/ZJHCCZh7_normal.jpg","description":"Hello, I'm the General Director of the Sonora Cancer Research Center (CICS). I'm happy to contribute in Cancer projects with clinical relevance.","id_on_source":"Francis_Rdgz","tweeter_id":"747459371735494656","geo":{"lt":null,"ln":null},"followers":628},"tweet_id":"804373107448238080"},{"url":"http:\/\/twitter.com\/DrKynast\/statuses\/875479394881601537","license":"gnip","citation_ids":[14165161],"posted_on":"2017-06-15T22:25:28+00:00","author":{"name":"Dr.med. Bernd Kynast","image":"https:\/\/pbs.twimg.com\/profile_images\/773512285629345792\/2AmdEU5W_normal.jpg","description":"Medical Oncology, Molecular Genetics, Medical & Business Consultancy, Commander (Navy, Reserve) \u00a7 Unfollow=blocked #Passion4America","id_on_source":"DrKynast","tweeter_id":"773340859303682049","geo":{"lt":null,"ln":null},"followers":2107},"tweet_id":"875479394881601537"}]}}